NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report)’s share price was up 6% on Thursday . The stock traded as high as $3.11 and last traded at $3.09. Approximately 1,143 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 9,252 shares. The stock had previously closed at $2.92.
NeurAxis Stock Performance
The business has a 50-day moving average of $3.07 and a 200-day moving average of $3.09. The stock has a market capitalization of $17.28 million and a price-to-earnings ratio of -0.69.
NeurAxis (NASDAQ:NRXS – Get Free Report) last released its earnings results on Friday, August 9th. The company reported ($0.42) earnings per share for the quarter. The company had revenue of $0.61 million for the quarter.
NeurAxis Company Profile
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Further Reading
- Five stocks we like better than NeurAxis
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Best Stocks Under $5.00
- MarketBeat Week in Review – 9/16 – 9/20
- How to Invest in Insurance Companies: A Guide
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
